<!DOCTYPE html>
<html>
<head>
<title>Cluster3-52 Analysis</title>

    <style>
            body {{
                font-family: Arial, sans-serif;
                background-color: #f5f5f5;
                color: #333333;
                margin: 0;
                padding: 0;
            }}

            h1 {{
                font-size: 2em;
                margin: 0 0 0.5em;
            }}

            ul {{
                list-style-type: none;
                margin: 0;
                padding: 0;
            }}

            li {{
                font-size: 1.2em;
                margin: 0;
            }}

            .container {{
                max-width: 800px;
                margin: 0 auto;
                padding: 2em;
                background-color: #ffffff;
            }}
        </style> 
        
</head>
<body>
<h1>Cluster3-52 System Summary</h1>
<h2>Proteins</h2>
<p>TADA2A, NEUROG3, TADA2B, ATXN7L3, USP22, TAF5L, TCF12</p>
<h2>GPT 4 Analysis</h2><h3>Human SAGA-TFTC Transcriptional Coactivator Complex</h3><h4>Summary</h4><div><summary><br>The human protein system analyzed consists of TADA2A, NEUROG3, TADA2B, ATXN7L3, USP22, TAF5L, and TCF12. These proteins are involved in transcription by RNA polymerase II, DNA-templated transcription, and transcription coactivator activity. The majority of these proteins are components of the SAGA complex and the transcription factor TFTC complex, which play essential roles in histone H3 acetylation, chromatin remodeling, and RNA splicing. The proposed name for this system is the Human SAGA-TFTC Transcriptional Coactivator Complex, reflecting its cellular location and function.<br></summary></div><h4>Reference</h4><div><references><br>1. Grant, P. A., Duggan, L., Côté, J., Roberts, S. M., Brownell, J. E., Candau, R., ... &amp; Workman, J. L. (1997). Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes &amp; development, 11(13), 1640-1650.<br><br>2. Martinez, E., Palhan, V. B., Tjernberg, A., Lymar, E. S., Gamper, A. M., Kundu, T. K., ... &amp; Roeder, R. G. (2001). Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Molecular and cellular biology, 21(20), 6782-6795.<br><br>3. Zhao, Y., Lang, G., Ito, S., Bonnet, J., Metzger, E., Sawatsubashi, S., ... &amp; Günther, T. (2008). A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Molecular cell, 29(1), 92-101.<br><br>4. Gradwohl, G., Dierich, A., LeMeur, M., &amp; Guillemot, F. (2000). neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proceedings of the National Academy of Sciences, 97(4), 1607-1611.<br><br>5. Seo, S., Lim, J. W., Yellajoshyula, D., Chang, L. W., &amp; Kroll, K. L. (2007). Neurogenin and NeuroD direct transcriptional targets and their regulatory enhancers. The EMBO journal, 26(24), 5093-5108.<br></references></div>
<h2>Gene Feature Summary</h2>
<table>
<thead>
<tr>
<th>Feature</th><th>Number of Genes</th><th>Genes</th></tr>
</thead>
<tbody>
<tr>
<td>protein binding</td><td>7</td><td>TADA2A, NEUROG3, TADA2B, ATXN7L3, USP22, TAF5L, TCF12</td></tr>
<tr>
<td> transcription by RNA polymerase II</td><td>7</td><td>TADA2A, NEUROG3, TADA2B, ATXN7L3, USP22, TAF5L, TCF12</td></tr>
<tr>
<td> DNA-templated transcription</td><td>6</td><td>TADA2A, NEUROG3, TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>nucleus</td><td>6</td><td>TADA2A, NEUROG3, TADA2B, ATXN7L3, TAF5L, TCF12</td></tr>
<tr>
<td>transcription coactivator activity</td><td>5</td><td>TADA2A, TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>histone H3 acetylation</td><td>5</td><td>TADA2A, TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>SAGA complex</td><td>5</td><td>TADA2A, TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>zinc ion binding</td><td>4</td><td>TADA2A, TADA2B, ATXN7L3, USP22</td></tr>
<tr>
<td> DNA repair</td><td>4</td><td>TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>monoubiquitinated histone deubiquitination</td><td>4</td><td>TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>monoubiquitinated histone H2A deubiquitination</td><td>4</td><td>TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td> RNA splicing</td><td>4</td><td>TADA2B, ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>chromatin remodeling</td><td>3</td><td>TADA2A, TADA2B, USP22</td></tr>
<tr>
<td>nucleoplasm</td><td>3</td><td>TADA2B, USP22, TCF12</td></tr>
<tr>
<td>transcription factor TFTC complex</td><td>3</td><td>ATXN7L3, USP22, TAF5L</td></tr>
<tr>
<td>chromatin binding</td><td>2</td><td>TADA2A, TADA2B</td></tr>
<tr>
<td>histone acetylation</td><td>2</td><td>TADA2A, TAF5L</td></tr>
<tr>
<td> histone acetylation</td><td>2</td><td>TADA2A, TADA2B</td></tr>
<tr>
<td>SAGA-type complex</td><td>2</td><td>TADA2A, TADA2B</td></tr>
<tr>
<td>RNA polymerase II cis-regulatory region sequence-specific DNA binding</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>DNA-binding transcription factor activity, RNA polymerase II-specific</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>DNA-binding transcription activator activity, RNA polymerase II-specific</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>DNA-binding transcription factor activity</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>E-box binding</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>nervous system development</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td> neuron differentiation</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>chromatin</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>cytoplasm</td><td>2</td><td>NEUROG3, TCF12</td></tr>
<tr>
<td>nuclear receptor coactivator activity</td><td>2</td><td>ATXN7L3, USP22</td></tr>
<tr>
<td>nuclear speck</td><td>2</td><td>TAF5L, TCF12</td></tr>
</tbody>
</table>
</body>
</html>